| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0006 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0007 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0008 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0008 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.24 | 0.0009 |